Rein Therapeutics provides clinical trial update for Phase 2 ReNEW Study of LTI-03 in idiopathic pulmonary fibrosis

Published: 2026-04-29 12:53:55 ET RNTX

Published on 04/29/2026 at 12:53 pm EDT